Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-18-008132
Filing Date
2018-04-30
Accepted
2018-04-30 15:48:16
Documents
4
Period of Report
2018-06-14
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dffn20180427_def14a.htm DEF 14A 626467
2 proxy2.jpg GRAPHIC 104426
3 proxy1.jpg GRAPHIC 237603
4 dffn20180420_pre14aimg001.jpg GRAPHIC 10370
  Complete submission text file 0001437749-18-008132.txt   1113243
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 18789417
SIC: 2834 Pharmaceutical Preparations